₹ 1.8 Cr
Volume transacted
15.4 K
stocks traded
Last Updated time: 18 Sep 9.00 AM
Alembic Pharmaceuticals Ltd
NSE: APLLTD
YEARLOW
₹ 707.5
Last updated: 18 Sep 24
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
No data available
* All values are consolidated
Last Updated time:
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price | Day Open | Day High | Day Low |
---|
18 Sep 2024 | 1188.75 | 1217.4 | 1223.3 | 1180 |
17 Sep 2024 | 1200.4 | 1190 | 1222.75 | 1187.3 |
16 Sep 2024 | 1182.3 | 1202.15 | 1224.7 | 1176.85 |
13 Sep 2024 | 1208.55 | 1239.65 | 1239.65 | 1200.8 |
12 Sep 2024 | 1216.4 | 1241 | 1277 | 1211.55 |
11 Sep 2024 | 1248.6 | 1242.6 | 1252.75 | 1212 |
10 Sep 2024 | 1243.25 | 1200.6 | 1250.2 | 1168.55 |
09 Sep 2024 | 1204.15 | 1101.05 | 1218 | 1101.05 |
06 Sep 2024 | 1107.65 | 1158.05 | 1174 | 1100.9 |
05 Sep 2024 | 1148.5 | 1134.85 | 1170.6 | 1125.8 |
Date | Price |
---|---|
18 Sep 2024 | 1188.75 |
17 Sep 2024 | 1200.4 |
16 Sep 2024 | 1182.3 |
13 Sep 2024 | 1208.55 |
12 Sep 2024 | 1216.4 |
11 Sep 2024 | 1248.6 |
10 Sep 2024 | 1243.25 |
09 Sep 2024 | 1204.15 |
06 Sep 2024 | 1107.65 |
05 Sep 2024 | 1148.5 |
Market Value
₹ 0
Asset Value
₹ 0
* All values are in Rupees
Historical Revenue of Alembic Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
No data available
* All values are in ₹ crore
Historical Net Profit of Alembic Pharmaceuticals Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
No data available
* All values are in ₹ crore
Alembic Pharmaceuticals appoints Head - Technical Operations (Sterile & Oncology)
Alembic Pharmaceuticals has appointed Sudhakar Pandiyan as Head - Technical Operations (St...
Read more
16 Sep 202417:45
Alembic Pharmaceuticals receives USFDA final approval for Albendazole Tablets
Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration...
Read more
05 Sep 202413:21
Alembic Pharma gains after receiving USFDA nod for Betamethasone Valerate Foam
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD)...
Read more
26 Aug 202409:55
Alembic Pharmaceuticals receives USFDA approval for Betamethasone Valerate Foam
Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration...
Read more
24 Aug 202414:03
Alembic Pharma gets USFDA nod for Betamethasone Valerate Foam
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD)...
Read more
24 Aug 202416:59
Alembic Pharma receives USFDA approval for Dabigatran Etexilate Capsules
Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration...
Read more
13 Aug 202412:15
FAQs for 52 Week Low of Alembic Pharmaceuticals Ltd
Why is it important to track the 52-week low of Alembic Pharmaceuticals Ltd stocks?
What factors can lead to Alembic Pharmaceuticals Ltd stocks hitting a 52-week low?
Should investors buy Alembic Pharmaceuticals Ltd stocks when they hit a 52-week low?
How often should investors monitor the 52-week low of Alembic Pharmaceuticals Ltd stocks?
How can an investor assess the risk of buying Alembic Pharmaceuticals Ltd stock at their 52-week low?
Should investors consider the overall market trend when evaluating Alembic Pharmaceuticals Ltd stocks at their 52-week low?
Unlimited trading at just
Rs. 199*